The tweet was deleted by the author.
But we saved everything 🙂.
Quantum-Si is in the spotlight at the ASMS conference today as collaborators from the University of Virginia, including Dr. G Sheynkman and Dr. Natchanon Sittipongpittaya, present their latest data on post-translational modification (PTM) detection.
Attendees are encouraged to connect with Quantum-Si users to gain firsthand insights into recent advancements. The event underscores the company’s ongoing work in proteomics innovation and its close ties with leading academic researchers.
Earlier this year, Quantum-Si CEO Jeff Hawkins was scheduled to join a fireside chat at the H.C.Wainwright BioConnect Investor Conference. The company also provided a live webcast registration for the event. These activities highlight continued engagement with investors and the scientific community.